US Patent 7326705 Heterocyclic sodium/proton exchange inhibitors and method

Patent 7326705 was granted and assigned to Bristol-Myers Squibb on February, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Bristol-Myers Squibb

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

73267050

Patent Inventor Names

David S. Weinstein0

Saleem Ahmad0

Shung C. Wu0

Steven V. O'Neil0

Karnail S. Atwal0

Khehyong Ngu0

Date of Patent

February 5, 2008

Patent Application Number

110469930

Date Filed

January 31, 2005

Patent Primary Examiner

‌

Jeffrey Murray

Patent abstract

Heterocyclic are provided which are sodium/proton exchange (NHE) inhibitors which have the structure

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7326705 Heterocyclic sodium/proton exchange inhibitors and method

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API